Cenntro Electric (CENN) had the best year in Q3 2012 by a US stock in 2012, returning 114,285,614.3%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Cenntro Electric (CENN) | 2012 | 114,285,614.27% |
Nixxy (NIXX) | 2012 | 568,900% |
DiaMedica Therapeutics (DMAC) | 2012 | 2,027.73% |
Par Pacific (PARR) | 2012 | 1,650% |
Netcapital (NCPL) | 2012 | 533.33% |
Skeena Resources (SKE) | 2012 | 382.35% |
TOMI Environmental Solutions (TOMZ) | 2012 | 354.55% |
Sarepta Therapeutics (SRPT) | 2012 | 324.32% |
Astrana Health (ASTH) | 2012 | 275% |
Intrusion (INTZ) | 2012 | 253.1% |
Harrow Health (HROW) | 2012 | 216.67% |
Catalyst Pharmaceuticals (CPRX) | 2012 | 196.08% |
Paysign (PAYS) | 2012 | 175% |
Viewbix Inc Common Stock (VBIX) | 2012 | 165.15% |
Anfield Energy (AEC) | 2012 | 155.56% |
Ryvyl (RVYL) | 2012 | 150% |
Microbot Medical (MBOT) | 2012 | 145.24% |
Supercom (SPCB) | 2012 | 133.33% |
Anixa Biosciences (ANIX) | 2012 | 125.71% |
Northern Dynasty Minerals (NAK) | 2012 | 98.27% |
BV Financial, Inc Common Stock (BVFL) | 2012 | 96.08% |
Cosmos Health (COSM) | 2012 | 95% |
Transcontinental Realty Investors (TCI) | 2012 | 94.35% |
Dyadic International (DYAI) | 2012 | 93.33% |
Sunshine Biopharma (SBFM) | 2012 | 93.33% |